This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Spinal cord injury patients report regained sensation in human neural stem cells clinical trial

September 5th, 2012

Swiss doctors with the world's first clinical trial using human neural stem cells to treat chronic thoracic spinal cord injury report that two patients have regained some ability to feel touch and heat.

These results raise hope that the treatment, which was created by StemCells Inc. and established in pre-clinical testing by Aileen Anderson and Brian Cummings at UC Irvine's Sue & Bill Gross Stem Cell Research Center, may help restore lost body function for the millions paralyzed by damage to their spinal cords. Researchers from Balgrist University Hospital in Zurich, where the patients were treated, presented the data in London at the annual meeting of the International Spinal Cord Society.

The Phase I/II trial reported earlier this year positive safety data from the first cohort of treated patients and continues to enroll subjects from the U.S., Canada and Europe. In July, Anderson and Cummings, in collaboration with StemCells Inc., received a $20 million award from the California stem cell research funding agency, CIRM, to develop human clinical trials for cervical spinal cord injury.

Provided by University of California, Irvine

Citation: Spinal cord injury patients report regained sensation in human neural stem cells clinical trial (2012, September 5) retrieved 26 April 2024 from https://sciencex.com/wire-news/108278517/spinal-cord-injury-patients-report-regained-sensation-in-human-n.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.